Tyrosine phosphatase SHP-2 is a mediator of activity-dependent neuronal excitotoxicity

Gabriel Rusanescu1, Wentian Yang, Ailin Bai

  • 1Department of Biochemistry, Tufts University School of Medicine, Boston, MA 02111, USA.

The EMBO Journal
|January 15, 2005
PubMed

Insights

Excessive calcium influx triggers a pathway involving tyrosine phosphatase Shp-2, which suppresses brain-derived neurotrophic factor (BDNF) signaling, leading to neuronal death. Inhibiting Shp-2 enhances neuronal survival.

Area of Science:

  • Neuroscience
  • Cell Signaling
  • Molecular Biology

Background:

  • Calcium influx is crucial for neuronal function but excessive levels can cause cell death.
  • Neurotrophins like BDNF promote neuronal survival by activating pathways such as Ras/Erk and Akt.
  • Understanding the molecular mechanisms linking calcium levels to neurotrophin signaling is vital for neurodegenerative disease research.

Purpose of the Study:

  • To identify novel signaling pathways involved in calcium-induced neuronal cell death.
  • To investigate the role of calcium influx in regulating brain-derived neurotrophic factor (BDNF) signaling.
  • To elucidate the mechanism by which calcium influx sensitizes cerebellar neurons to excitotoxicity.

Main Methods:

  • Utilized cerebellar neuronal cultures.
  • Investigated calcium influx via L-type voltage-sensitive calcium channels and glutamate receptors.
  • Assessed the interaction between tyrosine phosphatase Shp-2 and TrkB receptors.
  • Examined the impact of Shp-2 gene deletion on neuronal survival under excitotoxic conditions.

Main Results:

  • Calcium influx suppressed BDNF activation of Ras, Erk, and Akt pathways.
  • Enhanced association of Shp-2 with TrkB receptors inhibited BDNF-induced TrkB autophosphorylation.
  • Deletion of the Shp2 gene in neurons reversed TrkB inhibition and increased survival.
  • These findings reveal a feedback mechanism where calcium negatively regulates neurotrophin signaling.

Conclusions:

  • Shp-2 acts as a critical mediator in a calcium-initiated feedback loop that impairs neurotrophin signaling.
  • This Shp-2-mediated pathway sensitizes cerebellar neurons to excitotoxicity and neurodegeneration.
  • Targeting Shp-2 may offer a therapeutic strategy for conditions involving excitotoxicity and neurodegenerative diseases.

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
85.4K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.6K
Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
12.4K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.0K